Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The rating reduction from 60 percent to 10 percent for eczema and seborrheic dermatitis effective July 1, 2020 was improper. The Veteran's skin condition has not improved as evidenced by the varying coverage of his skin issues. As a result, the 60 percent rating is restored.

The deciding factor: The evidence does not show an improvement in the Veteran's ability to function under ordinary conditions of life due to the fluctuating nature of his skin condition.

Claimed conditions
eczema, seborrheic dermatitis
How they argued it
Direct service connection
Exposure basis
None
Rating
Not verified here — check the original decision
Decision date
April 26, 2024
Citation
A24021575

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A24021575.

What this means for you

A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.